These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17477886)

  • 21. Agomelatine restores a physiological response to stress in the aged rat.
    Descamps A; Rousset C; Dugua H; Debilly G; Delagrange P; Cespuglio R
    Neurosci Lett; 2014 Apr; 566():257-62. PubMed ID: 24602983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Agomelatine: the first "melatoninergic" antidepressant].
    Bánki MC
    Neuropsychopharmacol Hung; 2006 Oct; 8(3):105-12. PubMed ID: 17211046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placebo-controlled trial of agomelatine in the treatment of major depressive disorder.
    Kennedy SH; Emsley R
    Eur Neuropsychopharmacol; 2006 Feb; 16(2):93-100. PubMed ID: 16249073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of early symptom relief in antidepressant treatment: focus on agomelatine.
    Lam RW
    J Psychopharmacol; 2010 Aug; 24(2 Suppl):27-30. PubMed ID: 20663806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice.
    De Berardis D; Fornaro M; Orsolini L; Iasevoli F; Tomasetti C; de Bartolomeis A; Serroni N; De Lauretis I; Girinelli G; Mazza M; Valchera A; Carano A; Vellante F; Matarazzo I; Perna G; Martinotti G; Di Giannantonio M
    CNS Spectr; 2017 Aug; 22(4):342-347. PubMed ID: 27702411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine.
    Shen J; Chung SA; Kayumov L; Moller H; Hossain N; Wang X; Deb P; Sun F; Huang X; Novak M; Appleton D; Shapiro CM
    Can J Psychiatry; 2006 Jan; 51(1):27-34. PubMed ID: 16491981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agomelatine, a melatonin agonist with antidepressant properties.
    Dubovsky SL; Warren C
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1533-40. PubMed ID: 19758108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatoninergic agonist and selective 5HT2C receptors antagonist, in the treatment of major depressive disorders].
    Lôo H; Daléry J; Macher JP; Payen A
    Encephale; 2002; 28(4):356-62. PubMed ID: 12232545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agomelatine as chronopsychopharmaceutics restoring circadian rhythms and enhancing resilience to stress: a wishfull thinking or an innovative strategy for superior management of depression?
    Jakovljević M
    Psychiatr Danub; 2011 Mar; 23(1):2-9. PubMed ID: 21448091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of agomelatine and mirtazapine on sleep disturbances in major depressive disorder: evidence from polysomnographic and resting-state functional connectivity analyses.
    Mi WF; Tabarak S; Wang L; Zhang SZ; Lin X; Du LT; Liu Z; Bao YP; Gao XJ; Zhang WH; Wang XQ; Fan TT; Li LZ; Hao XN; Fu Y; Shi Y; Guo LH; Sun HQ; Liu L; Si TM; Zhang HY; Lu L; Li SX
    Sleep; 2020 Nov; 43(11):. PubMed ID: 32406918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Agomelatine and Fluoxetine on HAM-D Score, Serum Brain-Derived Neurotrophic Factor, and Tumor Necrosis Factor-α Level in Patients With Major Depressive Disorder With Severe Depression.
    Gupta K; Gupta R; Bhatia MS; Tripathi AK; Gupta LK
    J Clin Pharmacol; 2017 Dec; 57(12):1519-1526. PubMed ID: 28833192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polysomnographic characteristics of bipolar hypomanic patients: Comparison with unipolar depressed patients.
    Asaad T; Sabry W; Rabie M; El-Rassas H
    J Affect Disord; 2016 Feb; 191():274-9. PubMed ID: 26688496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-REM sleep instability in patients with major depressive disorder: subjective improvement and improvement of non-REM sleep instability with treatment (Agomelatine).
    Lopes MC; Quera-Salva MA; Guilleminault C
    Sleep Med; 2007 Dec; 9(1):33-41. PubMed ID: 17826314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focus on agomelatine.
    Green B
    Curr Med Res Opin; 2011 Apr; 27(4):745-9. PubMed ID: 21271795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating each and every depressed patient.
    Kennedy SH
    J Psychopharmacol; 2008 Sep; 22(7 Suppl):19-23. PubMed ID: 18753279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of depression and melatonergic antidepressant treatment alone and in combination with sedative-hypnotics on heart rate variability: Implications for cardiovascular risk.
    Chang CC; Tzeng NS; Yeh CB; Kuo TBJ; Huang SY; Chang HA
    World J Biol Psychiatry; 2018 Aug; 19(5):368-378. PubMed ID: 28281386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effect of zopiclone and brotizolam on sleep EEG by quantitative evaluation in healthy young women.
    Kim YD; Zhuang HY; Tsutsumi M; Okabe A; Kurachi M; Kamikawa Y
    Sleep; 1993 Oct; 16(7):655-61. PubMed ID: 8290860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agomelatine: efficacy at each phase of antidepressant treatment.
    Kennedy SH
    CNS Drugs; 2009; 23 Suppl 2():41-7. PubMed ID: 19708725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-quality remission: potential benefits of the melatonergic approach for patients with major depressive disorder.
    Lam RW
    Int Clin Psychopharmacol; 2007 Oct; 22 Suppl 2():S21-5. PubMed ID: 17917563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
    Zajecka J; Schatzberg A; Stahl S; Shah A; Caputo A; Post A
    J Clin Psychopharmacol; 2010 Apr; 30(2):135-44. PubMed ID: 20520286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.